Therapeutic potential of tumor-infiltrating lymphocytes in non-small cell lung cancer.

Autor: Plaugher DR; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY, 40536, USA. Electronic address: plaugher_dr@uky.edu., Childress AR; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY, 40536, USA., Gosser CM; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY, 40536, USA., Esoe DP; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY, 40536, USA., Naughton KJ; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY, 40536, USA., Hao Z; Department of Internal Medicine - Medical Oncology, University of Kentucky, Lexington, KY, 40536, USA; Markey Cancer Center, University of Kentucky, Lexington, KY, 40536, USA., Brainson CF; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY, 40536, USA; Markey Cancer Center, University of Kentucky, Lexington, KY, 40536, USA. Electronic address: cfbrainson@uky.edu.

Publikováno v: Cancer letters [Cancer Lett] 2024 Oct 05; Vol. 605, pp. 217281. Date of Electronic Publication: 2024 Oct 05.

Polycomb deficiency drives a FOXP2-high aggressive state targetable by epigenetic inhibitors.

Autor: Chen F; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY, 40536, USA.; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, 510060, Guangzhou, P. R. China., Byrd AL; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY, 40536, USA., Liu J; Department of Internal Medicine, University of Kentucky, Lexington, KY, 40536, USA., Flight RM; Department of Molecular & Cellular Biochemistry, University of Kentucky, Lexington, KY, 40536, USA.; Markey Cancer Center, University of Kentucky, Lexington, KY, 40536, USA., DuCote TJ; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY, 40536, USA., Naughton KJ; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY, 40536, USA., Song X; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY, 40536, USA., Edgin AR; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY, 40536, USA., Lukyanchuk A; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY, 40536, USA., Dixon DT; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY, 40536, USA., Gosser CM; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY, 40536, USA., Esoe DP; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY, 40536, USA., Jayswal RD; Markey Cancer Center Biostatistics and Bioinformatics Shared Resource Facility, Lexington, KY, 40536, USA., Orkin SH; Department of Hematology/Oncology, Boston Children's Hospital, Boston, MA, 02115, USA., Moseley HNB; Department of Molecular & Cellular Biochemistry, University of Kentucky, Lexington, KY, 40536, USA.; Markey Cancer Center, University of Kentucky, Lexington, KY, 40536, USA., Wang C; Department of Internal Medicine, University of Kentucky, Lexington, KY, 40536, USA.; Markey Cancer Center, University of Kentucky, Lexington, KY, 40536, USA., Brainson CF; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY, 40536, USA. cfbrainson@uky.edu.; Markey Cancer Center, University of Kentucky, Lexington, KY, 40536, USA. cfbrainson@uky.edu.

Publikováno v: Nature communications [Nat Commun] 2023 Jan 20; Vol. 14 (1), pp. 336. Date of Electronic Publication: 2023 Jan 20.